189 related articles for article (PubMed ID: 25003519)
21. Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade.
Breunis WB; Tarazona-Santos E; Chen R; Kiley M; Rosenberg SA; Chanock SJ
J Immunother; 2008; 31(6):586-90. PubMed ID: 18528295
[TBL] [Abstract][Full Text] [Related]
22. CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.
Qin XY; Lu J; Li GX; Wen L; Liu Y; Xu LP; Chang YJ; Liu KY; Jiang ZF; Huang XJ
Ann Hematol; 2018 Mar; 97(3):485-495. PubMed ID: 29264740
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
[TBL] [Abstract][Full Text] [Related]
24. Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism.
Patel H; Mansuri MS; Singh M; Begum R; Shastri M; Misra A
PLoS One; 2016; 11(3):e0149441. PubMed ID: 26963610
[TBL] [Abstract][Full Text] [Related]
25. Association between the CTLA4 +49A/G (rs231775) and CT60 (rs3087243) gene variants with vitiligo: study on a Mexican population.
Salinas-Santander MA; Suárez-Valencia VJ; Ángel-Martínez MD; Kubelis-Lopez DE; Zapata-Salazar NA; Ocampo-Garza JA; Ocampo-Candiani J
An Bras Dermatol; 2022; 97(6):710-715. PubMed ID: 36163113
[TBL] [Abstract][Full Text] [Related]
26. CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data.
Birlea SA; Laberge GS; Procopciuc LM; Fain PR; Spritz RA
Pigment Cell Melanoma Res; 2009 Apr; 22(2):230-4. PubMed ID: 19175525
[TBL] [Abstract][Full Text] [Related]
27. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
[TBL] [Abstract][Full Text] [Related]
28. Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations.
Creary LE; Gangavarapu S; Caillier SJ; Cavalcante P; Frangiamore R; Lie BA; Bengtsson M; Harbo HF; Brauner S; Hollenbach JA; Oksenberg JR; Bernasconi P; Maniaol AH; Hammarström L; Mantegazza R; Fernández-Viña MA
Front Immunol; 2021; 12():667336. PubMed ID: 34163474
[TBL] [Abstract][Full Text] [Related]
29. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
30. Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.
Fang M; Huang W; Mo D; Zhao W; Huang R
Cell Physiol Biochem; 2018; 47(1):414-427. PubMed ID: 29794444
[TBL] [Abstract][Full Text] [Related]
31. CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China.
Liu CP; Jiang JA; Wang T; Liu XM; Gao L; Zhu RR; Shen Y; Wu M; Xu T; Zhang XG
Genet Mol Res; 2013 Apr; 12(2):1373-82. PubMed ID: 23661460
[TBL] [Abstract][Full Text] [Related]
32. Investigation of CTLA-4 and CD86 gene polymorphisms in Iranian patients with brucellosis infection.
Eskandari-Nasab E; Moghadampour M; Najibi H; Hadadi-Fishani M
Microbiol Immunol; 2014 Feb; 58(2):135-41. PubMed ID: 24298899
[TBL] [Abstract][Full Text] [Related]
33. Association analysis of PTPN22, CTLA4 and IFIH1 genes with type 1 diabetes in Colombian families.
Rodríguez A; Alfaro JM; Balthazar V; Pineda Trujillo N
J Diabetes; 2015 May; 7(3):402-10. PubMed ID: 25042601
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case-control association study in the Italian population.
Megiorni F; Mora B; Maxia C; Gerardi M; Pizzuti A; Rossi A
Arch Dermatol Res; 2013 Sep; 305(7):665-70. PubMed ID: 23567921
[TBL] [Abstract][Full Text] [Related]
35. HCV F protein amplifies the predictions of IL-28B and CTLA-4 polymorphisms about the susceptibility and outcomes of HCV infection in Southeast China.
Xiao W; Zhang Q; Deng XZ; Jiang LF; Zhu DY; Pei JP; Ge CY; Li BJ; Wang CJ; Zhang JH; Zhou ZX; Ding WL; Xu XD; Yue M
Infect Genet Evol; 2015 Aug; 34():52-60. PubMed ID: 26079279
[TBL] [Abstract][Full Text] [Related]
36. Association of CTLA4 gene polymorphisms with lymphatic filariasis in an East Malaysian population.
Idris ZM; Miswan N; Muhi J; Mohd TA; Kun JF; Noordin R
Hum Immunol; 2011 Jul; 72(7):607-12. PubMed ID: 21513760
[TBL] [Abstract][Full Text] [Related]
37. Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients.
Guo Y; Gao J; Gao S; Shang M; Guo F
Oncotarget; 2016 Apr; 7(17):23088-95. PubMed ID: 27081086
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
[TBL] [Abstract][Full Text] [Related]
39. Association of AIRE (rs2075876), but not CTLA4 (rs231775) polymorphisms with systemic lupus erythematosus.
Alghamdi SA; Kattan SW; Toraih EA; Alrowaili MG; Fawzy MS; Elshazli RM
Gene; 2021 Feb; 768():145270. PubMed ID: 33122082
[TBL] [Abstract][Full Text] [Related]
40. Correlations of TNF-α gene promoter polymorphisms with the risk of thymoma-associated myasthenia gravis in a northern Chinese Han population.
Yang HW; Lei P; Xie YC; Han ZL; Li D; Wang SH; Sun ZL
Cancer Gene Ther; 2017 Jun; 24(6):259-266. PubMed ID: 28429750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
